BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm.

Daniele Martinelli,Sebastiano Arceri,Roberto De Icco,Marta Allena,Elena Guaschino,Natascia Ghiotto,Vito Bitetto,Gloria Castellazzi,Giuseppe Cosentino,Grazia Sances,Cristina Tassorelli

TOXICON（2022）

引用 3|浏览1

暂无评分

摘要

The findings suggest that, when administered according to the PREEMPT paradigm, onabotulinum toxin-A is effective in the prevention of high-frequency episodic migraine. NCT04578782.

查看译文

关键词

BoNT-A,Migraine,high frequency episodic migraine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要